CClinicalTrials.gg
Active, not recruitingNCT06631482Updated Dec 17, 2025

Comparison Bewteen Intraoperative HPI vs. High Mean Arterial Pressure Threshold

An interventional study of Maintain HPI < 85 and Maintain MAP>=73 in Hypotension During Surgery, sponsored by National Taiwan University Hospital. Active, not recruiting at 2 sites in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-17.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Intraoperative hypotension (IOH) is a common and serious complication during surgery, closely associated with poor postoperative outcomes. Traditionally, anesthesiologists rely on real-time physiological parameters and alarms to monitor blood pressure, but the low alarm thresholds may lead to delayed interventions. The Hypotension Prediction Index (HPI) is a novel predictive tool that uses arterial waveform signals and advanced algorithms to forecast hypotensive events in advance. Recent observational studies have shown that HPI's accuracy in predicting hypotension is highly consistent with setting the physiological monitor's alarm threshold to 73 mmHg. This study will compare the effectiveness of HPI and a raised alarm threshold of 73 mmHg in preventing IOH. While HPI is promising with its AI-assisted approach to patient care, its high cost due to the advanced technology raises concerns. If its accuracy is comparable to simply raising the traditional monitor threshold, it may not lead to substantial changes in clinical practice.

Read the detailed description

Intraoperative hypotension (IOH) is a significant complication that affects surgical patients, potentially leading to adverse outcomes postoperatively. Standard practices involve relying on monitoring devices with low alarm thresholds for blood pressure, which may result in delayed interventions. The Hypotension Prediction Index (HPI) offers a predictive approach by analyzing arterial waveform signals and using complex algorithms to detect potential hypotensive episodes early. Recent observational studies have suggested that HPI's accuracy in predicting hypotension aligns closely with raising the physiological monitor alarm threshold to 73 mmHg. To further investigate this, this study will compare the effects of setting a traditional monitor alarm threshold at 73 mmHg with using HPI to prevent IOH.

In this study, patients will be randomly assigned to two groups. In the HPI group, interventions will be initiated when the HPI value exceeds 85. These interventions will follow a protocol that includes fluid administration, norepinephrine, and dobutamine to prevent hypotension. The control group will have their alarm threshold set at 73 mmHg. For these patients, interventions will be based on stroke volume variation (SVV) and clinical judgment, utilizing fluid and norepinephrine as needed. HPI is an attractive AI-based tool for medical care, but its high cost due to advanced technology raises questions. If its accuracy proves to be similar to simply raising the alarm threshold to 73 mmHg, it may not lead to meaningful changes in clinical practice. The study aims to compare the efficacy of these two methods in reducing the incidence of IOH.

02

Conditions studied

  • Hypotension During Surgery

Keywords

  • HPI
  • intraopeartive hypotension
  • overtreatment
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • A: Patients undergoing surgeries requiring general anesthesia lasting more than two hours, and requiring continuous arterial blood pressure monitoring via arterial catheter according to standard medical practice. This includes:

ASA Class II or higher. Estimated surgery duration of three hours or more. High cardiovascular risk, such as poorly controlled hypertension, diabetes, coronary artery disease, chronic kidney disease, or chronic emphysema.

  • B: Patients aged 18 years or older.

Exclusion criteria

Exclusion Criteria:

  • ASA Class I: Patients with mild systemic disease.
  • Pregnancy: Pregnant women.
  • End-stage renal disease: Patients with eGFR below 30 ml/min/1.73 m².
  • Cardiac shunt: Presence of intracardiac shunt.
  • Severe arrhythmias: Including supraventricular tachycardia (heart rate \&amp;gt;100 bpm), ventricular tachycardia, or ventricular fibrillation.
  • Factors affecting SVV accuracy: Conditions such as atrial fibrillation (A-Fib) or thoracic surgery that can invalidate stroke volume variation (SVV) measurements.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    HPI Group

    Use the hypotension predictive index (HPI)-guided protocol to prevent intraoperative hypotension, initiating treatmentusing the fluid administration or intravenous norepinephrine infusion to keep intraoperative HPI below 85.

    Device: Maintain HPI < 85

  • Active comparator
    73mmHg MAP Alarm Group

    Intraoperative maintenance of the mean arterial pressure (MAP) at 73 mmHg or higher by using the fluid administration or intravenous norepinephrine infusion.

    Drug: Maintain MAP>=73

Interventions

  • DeviceMaintain HPI < 85

    Protocolized treatment with fluid administration, norepinephrine, and dobutamine to prevent intraoperative hypotension. The two arms are triggered by different alarms: one from a traditional monitor with an elevated MAP threshold of 73 mmHg, and the other from an HPI threshold of 85.

  • DrugMaintain MAP>=73

    Protocolized treatment with fluid administration, norepinephrine, and dobutamine to prevent intraoperative hypotension. The two arms are triggered by different alarms: one from a traditional monitor with an elevated MAP threshold of 73 mmHg, and the other from an HPI threshold of 85.

06

What researchers measure

Primary outcomes

  1. Comparison of Time-Weighted Average (TWA) for MAP below 65 mmHg During Surgery

    The primary outcome will assess the time-weighted average (TWA) for both groups, comparing the duration and magnitude of mean arterial pressure (MAP) below 65 mmHg during surgery. This will help determine the effectiveness of the interventions in preventing intraoperative hypotension and hypertension.

    Time frame: From the start of surgery to the end of surgery, approximately up to 12 hours, depending on the duration of the operation.

  2. Comparison of Time-Weighted Average (TWA) for MAP above 100 mmHg During Surgery

    The primary outcome will assess the time-weighted average (TWA) for both groups, comparing the duration and magnitude of mean arterial pressure (MAP) above 100 mmHg during surgery. This will help determine the effectiveness of the interventions in preventing intraoperative hypotension and hypertension.

    Time frame: From the start of surgery to the end of surgery, approximately up to 12 hours, depending on the duration of the operation.

Secondary outcomes

  1. 30-day mortality rate

    30-day mortality rate from the day of the surgery.

    Time frame: From the day of surgery to 30 days postoperatively.

  2. dosage of intraoperative interventions (such as vasopressors and fluids)

    The type, and dosage of intraoperative interventions (such as vasopressors and fluids) administered during surgery.

    Time frame: During the surgery (from induction of anesthesia to the end of surgery, approximately up to 12 hours, depending on the duration of the surbery).

  3. hospital stay

    Total hospital stay duration in days.

    Time frame: Approximately 7 days from the date of enrollment

07

Study locations

2 sites
  • National Taiwan University Hospital Hsin-Chu Branch
    Hsinchu, 302, Taiwan
  • National Taiwan University Hosipital
    Taipei, 100, Taiwan
08

References and documents

Publications

  • Mulder MP, Harmannij-Markusse M, Fresiello L, Donker DW, Potters JW. Hypotension Prediction Index Is Equally Effective in Predicting Intraoperative Hypotension during Noncardiac Surgery Compared to a Mean Arterial Pressure Threshold: A Prospective Observational Study. Anesthesiology. 2024 Sep 1;141(3):453-462. doi: 10.1097/ALN.0000000000004990. PubMed 38558038 ↗
  • Hatib F, Jian Z, Buddi S, Lee C, Settels J, Sibert K, Rinehart J, Cannesson M. Machine-learning Algorithm to Predict Hypotension Based on High-fidelity Arterial Pressure Waveform Analysis. Anesthesiology. 2018 Oct;129(4):663-674. doi: 10.1097/ALN.0000000000002300. PubMed 29894315 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06631482
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Oct 8, 2024
Start date
Sep 16, 2024
Primary completion
Oct 14, 2025
Completion
May 31, 2026 (estimated)
Last update
Dec 17, 2025

Study contacts

Tsung Ta Wu, MD.
principal investigator · National Taiwan University Hospital Hsinchu branch

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion